Track Turnstone Biologics Corp. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Turnstone Biologics Corp. Common Stock TSBX · Stock Open Turnstone Biologics Corp. Common Stock in new tab

0.3550 USD
EPS
-2.04
P/B
0.56
ROE
-126.71
Loading chart...
Key Metrics
EPS-2.04
Book Value0.64
Price to Book0.56
Debt/Equity2.78
% Insiders7.698%
Estimates
Forward P/E-0.15
Forward EPS-2.40

DCF Valuation

Tweak assumptions to recompute fair value for Turnstone Biologics Corp. Common Stock (TSBX)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Turnstone Biologics Corp. Common Stock Logo Turnstone Biologics Corp. Common Stock Analysis (TSBX)

United States Information Technology Official Website Stock

Is Turnstone Biologics Corp. Common Stock a good investment? Turnstone Biologics Corp. Common Stock (TSBX) is currently trading at 0.3550 USD.

Investor FAQ

Does Turnstone Biologics Corp. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Turnstone Biologics Corp. Common Stock?

Turnstone Biologics Corp. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Turnstone Biologics Corp. operates as a biotechnology company. The company was founded in 2014 and is headquartered in San Diego, California. As of August 11, 2025, Turnstone Biologics Corp. operates as a subsidiary of XOMA Royalty Corporation.

Exchange Ticker
NMS (United States) TSBX
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion